REICIN ALISE - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for REICIN ALISE
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2026-02-11
Purchase(A)
2026-03-05
4:30 pm
Tectonic Therapeutic Inc.TECXREICIN ALISE
Chief Executive Officer
2,500$21.1$52,750362,077
(Indirect
Direct)
View
2026-02-11
Purchase
2026-02-12
4:15 pm
Tectonic Therapeutic Inc.TECXREICIN ALISE
Chief Executive Officer
2,500$21.1$52,750362,077
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2026-03-18
7:28 pm
N/A
2034-07-28
Immatics N.V.IMTXREICIN ALISE
Director
0$0101,500
(Direct)
View
2026-03-04
Option Award
2026-03-05
5:47 pm
N/A
2036-03-03
Tectonic Therapeutic Inc.TECXREICIN ALISE
Chief Executive Officer
145,750$0507,827
(Direct)
View
2026-02-04
Tax Withholding
2026-02-10
4:07 pm
N/A
N/A
Tectonic Therapeutic Inc.TECXREICIN ALISE
Chief Executive Officer
4,104$23.22359,577
(Direct)
View
2025-12-31
Exercise
2026-01-05
5:02 pm
N/A
N/A
Tectonic Therapeutic Inc.TECXREICIN ALISE
Chief Executive Officer
10,966$2.38386,638
(Direct)
View
2025-12-31
Exercise
2026-01-05
5:02 pm
N/A
2031-06-27
Tectonic Therapeutic Inc.TECXREICIN ALISE
Chief Executive Officer
10,966$0386,638
(Direct)
View
2025-09-25
Option Award
2025-09-29
5:00 pm
N/A
2035-09-24
Tectonic Therapeutic Inc.TECXREICIN ALISE
Chief Executive Officer
41,410$0379,425
(Direct)
View
2025-06-20
Tax Withholding
2025-06-24
4:55 pm
N/A
N/A
Tectonic Therapeutic Inc.TECXREICIN ALISE
Chief Executive Officer
859$19.81338,015
(Direct)
View
2025-06-05
Option Award
2025-06-09
4:39 pm
N/A
2035-06-04
Sana Biotechnology Inc.SANAREICIN ALISE
Director
80,000$080,000
(Direct)
View
2025-02-04
Option Award
2025-02-06
4:05 pm
N/A
2035-02-03
Tectonic Therapeutic Inc.TECXREICIN ALISE
Chief Executive Officer
138,000$0440,827
(Direct)
View
2024-12-04
Option Award
2024-12-06
5:19 pm
N/A
2034-12-03
Tectonic Therapeutic Inc.TECXREICIN ALISE
Chief Executive Officer
17,717$0308,827
(Direct)
View
2024-06-06
Option Award(A)
2024-07-15
4:11 pm
N/A
2034-06-05
Sana Biotechnology Inc.SANAREICIN ALISE
Director
65,000$065,000
(Direct)
View
2024-06-20
Option Award
2024-06-24
4:12 pm
N/A
2031-06-27
Tectonic Therapeutic Inc.TECXREICIN ALISE
Chief Executive Officer
638,013$0638,013
(Direct)
View
2024-06-06
Option Award
2024-06-07
4:22 pm
N/A
2034-06-05
Sana Biotechnology Inc.SANAREICIN ALISE
Director
54,278$054,278
(Direct)
View
2023-06-14
Option Award
2023-06-15
6:04 pm
N/A
2033-06-14
Homology Medicines Inc.FIXXREICIN ALISE
Director
23,000$023,000
(Direct)
View
2023-06-08
Option Award
2023-06-09
4:34 pm
N/A
2033-06-07
Sana Biotechnology Inc.SANAREICIN ALISE
Director
65,000$065,000
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:05 pm
N/A
2032-06-15
Homology Medicines Inc.FIXXREICIN ALISE
Director
18,000$018,000
(Direct)
View
2022-06-06
Option Award
2022-06-08
6:39 pm
N/A
2032-06-05
Sana Biotechnology Inc.SANAREICIN ALISE
Director
65,000$065,000
(Direct)
View
2021-06-17
Option Award
2021-06-22
5:40 pm
N/A
2031-06-17
Homology Medicines Inc.FIXXREICIN ALISE
Director
18,000$018,000
(Direct)
View
(A) Indicate amendment filing.